PRP Injections & Treatment Systems in Las Vegas, NV

Las Vegas epidemiology first — then the SKU

CDC PLACES (2023, crude) estimates 12.5% of adults in Las Vegas have diagnosed diabetes — 0.5 points above the U.S. 12% figure. Obesity 32.4%; arthritis 24.3%. Those three PLACES crude rates (plus Census 646,790) are the local facts on this page. Everything else is the national prp injections catalog and JE paperwork.

The chart problems we still see in NV

• Adult arthritis here is 24.3% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. 17% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. PRP is autologous and not a 361 allograft, but “patient prefers regenerative” is still not medical necessity in Nevada.
• Nevada is outside CDC's historical Diabetes Belt core, but the national 12% diabetes figure still applies as a planning baseline until a clinic uses its own payer mix. Clinics asking for regenerative inventory still have to separate HCT/P 361 homologous-use products from unapproved “stem cell” claims (FDA 21 CFR 1271).
• Population 646,790 (Census city proper) understates metro demand and overstates how many of those people will ever see a biologic. Use it as scale, then underwrite against clinic specialty mix.

City rate, state belt, federal LCD — keep the grains

Nevada shares JE with CA, HI. Florida is the only single-state MAC. CDC PLACES (2023, crude) estimates 12.5% of adults in Las Vegas have diagnosed diabetes — 0.5 points above the U.S. 12% figure. If you also operate in another contractor’s state, say so on the first call — we map both.

Do this before you expand SKUs